10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of October 5, 2026, TXG trades at $95.60 with a market cap of $12.18B and a P/E ratio of -159.67. TXG moved +1.95% today. Year to date, TXG is +473.27%; over the trailing twelve months it is +659.54%. Its 52-week range spans $6.78 to $95.16. Analyst consensus is buy with an average price target of $63.21. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10x Genomics, Inc. Class A Common Stock (TXG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TXG moved +1.95% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $95.60 |
| Market Cap | $12.18B |
| P/E Ratio |
| -159.67 |
| EPS | $-0.59 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $95.16 |
|---|
| 52-Week Low | $6.78 |
|---|
| Volume | 1.13M |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $616.91M |
|---|
| Net Income | $-75.13M |
|---|
| Gross Margin | 70.03% |
|---|
16 analysts cover TXG: 0 strong buy, 7 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $63.21.